Phase II Study Evaluating Safety/Efficacy of OTX-DP for Treatment of Ocular Inflammation and Pain After Cataract Surgery
Status:
Completed
Trial end date:
2013-08-01
Target enrollment:
Participant gender:
Summary
To evaluate the safety and efficacy of OTX-DP as a sustained release drug (dexamethasone)
depot when placed in the canaliculus of the eyelid for the treatment of ocular inflammation
and pain in subjects who have undergone cataract extraction with intra-ocular lens
implantation.